A special Interview with Scott J. Knoer, MS, PharmD, FASHP, Named the 13th CEO/EVP of the American Pharmacists Association

The American Pharmacists Association announced today that Scott J. Knoer, MS, PharmD, FASHP, has been named the 13th Chief Executive Officer/Executive Vice President of APhA.

Dr. Knoer is the Chief Pharmacy Officer of the Cleveland Clinic, overseeing nearly 1,600 pharmacy FTEs and a $1.4 billion drug budget at the Clinic’s 1,300-bed tertiary care referral hospital, its clinics and cancer center, 18 family health centers and 11 community hospitals in the Cleveland area with facilities in Florida, Las Vegas, Canada, London and Abu Dhabi. He officially assumes his duties July 1, 2020. He succeeds Thomas E. Menighan, who has served as CEO/EVP of APhA for the past 11 years, and last year announced his plans to retire in 2020.

“I am humbled and honored to be named APhA’s 13th Chief Executive Officer and Executive Vice President,” said Dr. Knoer. “I have advocated hard for pharmacy throughout my career, and I’m excited to officially represent the entire profession, helping APhA to empower pharmacists to care for patients.

“Health care is transforming at a staggering pace,” Dr. Knoer continued. “While innovative medications are treating diseases once thought incurable, they often come at a price that is unsustainable for society. APhA will not only fight so pharmacists can care for their patients, but we will also fight to ensure that patients have access to affordable drug therapy.”

Prior to joining the Cleveland Clinic in 2011, Dr. Knoer held leadership positions in pharmacy at the University of Minnesota Medical Center in Fairview, Minn., and the University of Texas Medical Branch at Galveston, Tex. He completed his residency at the University of Kansas Medical Center and he is a graduate of the University of Nebraska College of Pharmacy.

“We are thrilled to announce Scott Knoer as the next CEO/EVP of the American Pharmacists Association, said Brad Tice, PharmD, MBA, FAPhA, President of APhA. “Scott brings a tremendous track record of leadership and organizational growth that will help drive APhA and the profession forward. He will be able to build on the tremendous work and foundation laid by Tom Menighan and previous CEOs of APhA, to take the organization to even greater heights. His experience across the health care ecosystem will be vital in helping the association navigate and strengthen the profession’s position as we move forward in this critical time for the profession in an increasingly complex healthcare system.”

“Congratulations to Dr. Knoer on his selection as the CEO of APhA to succeed me on July 1,” said APhA CEO/EVP Thomas E. Menighan, BPharm, MBA, ScD (Hon). “I am pleased with the board's diligence and their excellent selection. Scott brings tremendous talents, perspectives and experiences to us. I look forward to optimizing the transition.”

Sponsored by UltiGuard Safe Pack

https://www.ulticare.com/ultiguard-safe-pack/podcast  

A special Interview with Scott J. Knoer, MS, PharmD, FASHP, Named the 13th CEO/EVP of the American Pharmacists Association
The American Pharmacists Association announced today that Scott J. Knoer, MS, PharmD, FASHP, has been named the 13th&nbsp;Chief Executive Officer/Executive Vice President of APhA.
Dr. Knoer is the Chief Pharmacy Officer of the Cleveland Clinic, overseeing nearly 1,600 pharmacy FTEs and a $1.4 billion drug budget at the Clinic&rsquo;s 1,300-bed tertiary care referral hospital, its clinics and cancer center, 18 family health centers and 11 community hospitals in the Cleveland area with facilities in Florida, Las Vegas, Canada, London and Abu Dhabi. He officially assumes his duties July 1, 2020. He succeeds Thomas E. Menighan, who has served as CEO/EVP of APhA for the past 11 years, and last year announced his plans to retire in 2020.
&ldquo;I am humbled and honored to be named APhA&rsquo;s 13th&nbsp;Chief Executive Officer and Executive Vice President,&rdquo; said Dr. Knoer. &ldquo;I have advocated hard for pharmacy throughout my career, and I&rsquo;m excited to officially represent the entire profession, helping APhA to empower pharmacists to care for patients.
&ldquo;Health care is transforming at a staggering pace,&rdquo; Dr. Knoer continued. &ldquo;While innovative medications are treating diseases once thought incurable, they often come at a price that is unsustainable for society. APhA will not only fight so pharmacists can care for their patients, but we will also fight to ensure that patients have access to affordable drug therapy.&rdquo;
Prior to joining the Cleveland Clinic in 2011, Dr. Knoer held leadership positions in pharmacy at the University of Minnesota Medical Center in Fairview, Minn., and the University of Texas Medical Branch at Galveston, Tex. He completed his residency at the University of Kansas Medical Center and he is a graduate of the University of Nebraska College of Pharmacy.
&ldquo;We are thrilled to announce Scott Knoer as the next CEO/EVP of the American Pharmacists Association, said Brad Tice, PharmD, MBA, FAPhA, President of APhA. &ldquo;Scott brings a tremendous track record of leadership and organizational growth that will help drive APhA and the profession forward. He will be able to build on the tremendous work and foundation laid by Tom Menighan and previous CEOs of APhA, to take the organization to even greater heights. His experience across the health care ecosystem will be vital in helping the association navigate and strengthen the profession&rsquo;s position as we move forward in this critical time for the profession in an increasingly complex healthcare system.&rdquo;
&ldquo;Congratulations to Dr. Knoer on his selection as the CEO of APhA to succeed me on July 1,&rdquo; said APhA CEO/EVP Thomas E. Menighan, BPharm, MBA, ScD (Hon). &ldquo;I am pleased with the board's diligence and their excellent selection. Scott brings tremendous talents, perspectives and experiences to us. I look forward to optimizing the transition.&rdquo;
Sponsored by UltiGuard Safe Pack
<a href="https://www.ulticare.com/ultiguard-safe-pack/podcast">https://www.ulticare.com/ultiguard-safe-pack/podcast</a>&nbsp;&nbsp;

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.

The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.

The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.

The definition of “Innovation” is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare & the PPN is the Pharmacist's biggest fan. 

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.
The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.
The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.
The definition of &ldquo;Innovation&rdquo; is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare &amp; the PPN is the Pharmacist's biggest fan.&nbsp;

Pharmacy Podcast Network

The Pharmacy Podcast Network is ranked as the number one podcast in healthcare dedicated to the Business of Pharmacy and TOP 25 Podcasts in U.S. Business News. The most influential voices in the pharmacy industry are published on the Pharmacy Podcast Network (PPN). The PPN is the leading audio authority of the pharmaceutical & pharmacy industry with more than 30 hosts, 1,200+ episodes, supporting more than 25+ pharmacy industry associations, with more than 80,000 listeners world wide. 

The PPN is an Audio Branding & Public Relations Communications company dedicated to the Pharmaceutical industry focusing on Community, Long-term care, Health System, Specialty, pharmacy business supportive technologies, and industry trends. 

Pharmacy Podcast™ is a registered trademark

The Pharmacy Podcast Network is ranked as the number one podcast in healthcare dedicated to the Business of Pharmacy and TOP 25 Podcasts in U.S. Business News. The most influential voices in the pharmacy industry are published on the Pharmacy Podcast Network (PPN). The PPN is the leading audio authority of the pharmaceutical &amp; pharmacy industry with more than 30 hosts, 1,200+ episodes, supporting more than 25+ pharmacy industry associations, with more than 80,000 listeners world wide.&nbsp;
The PPN is an Audio Branding &amp; Public Relations Communications company dedicated to the Pharmaceutical industry focusing on Community, Long-term care, Health System, Specialty, pharmacy business supportive technologies, and industry trends.&nbsp;
Pharmacy Podcast&trade; is a registered trademark

Advertisement